4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Modify eGFR value as per standard guidelines: CDSCO Panel Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin31 Dec 2023 5:15 PM ISTNew Delhi: Reviewing the drug major Hetero Lab's revised Phase III clinical trial protocol of fixed-dose combination antidiabetic drug Sitagliptin...
Modify phase III clinical trial protocol: CDSCO panel tells Akum Pharma on antidiabetic FDCÂ Dr. Divya Colin17 Dec 2023 5:30 PM ISTNew Delhi: Approving to conduct the bioequivalence (BE) study of the antidiabetic drug combination Repaglinide plus Voglibose plus Metformin...
Present revised Phase III CT protocol : CDSCO Tells Hetero Lab on Antidiabetic FDC Drug Dr. Divya Colin6 March 2023 6:00 PM ISTNew Delhi: Granting permission to conduct the bioequivalence (BE) study for antidiabetic fixed dose combination (FDC) of Sitagliptin phosphate...
NPPA fixes retail price of 10 formulations Roshni Dhar21 Dec 2022 5:43 PM ISTThrough a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed...
Health Bulletin 21/December/2022 Roshni Dhar21 Dec 2022 5:09 PM ISTHere are the top health news for the day:Google will soon help translate doctor's handwritten prescriptionThe giant search engine, Google aims to...
NPPA Fixes Retail Price Of 10 Formulations, Details Susmita Roy20 Dec 2022 6:00 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
CDSCO panel rejects Emcure Voglibose, Vildagliptin FDC citing dosage schedule incompatibility between ingredients Farhat Nasim25 Dec 2020 1:18 PM ISTNew Delhi: Citing dosage schedule incompatibility between the ingredients, the Subject Expert Committee (SEC) functional under the Central Drugs...
